Can diet help with inflammatory bowel disease?
Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative colitis and Crohn's disease. In this expert alert, Amanda Johnson, M.D. , a gastroenterologist at Mayo Clinic, helps explain IBD and whether diet can help.
People with IBD may experience persistent symptoms like frequent diarrhea, weight loss, abdominal pain and fatigue. There is no cure and no exact cause, though researchers continue to look at how genes, the microbiome and environmental factors play a role in this chronic disease.
'Ulcerative colitis really tends to only involve the colon and be more of a superficial type inflammation; whereas Crohn's disease can impact anything in the intestine, essentially, from the mouth all the way down to the anus,' says Dr. Johnson.
She says diet alone does not cause IBD. While some foods may reduce symptoms, there is no one proven diet to control inflammation.
'The right diet is probably different for each individual, based on the type of IBD that they have, the location of their disease, whether they've had surgeries or other complications,' says Dr. Johnson.
Focus on fresh fruits and vegetables and whole grains. Avoid ultraprocessed foods, added sugars and animal fats. And drink plenty of water to stay hydrated.
Diet does not replace medical treatment. Dr. Johnson says there are effective treatment options, so it is important to work with your healthcare team.
'The tenant of therapy we have are immune-suppressing-type therapies that try to target that inappropriate response to the intestines and then calm down that inflammation within the gut,' she says.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
19-05-2025
- Zawya
Johnson & Johnson sets Guinness World Record with largest awareness ribbon mosaic
Inflammatory Bowel Disease (IBD) is a group of chronic inflammatory conditions of the gastrointestinal tract and is divided into Crohn's disease and ulcerative colitis [1] Johnson & Johnson, with the endorsement of the Emirates Gastroenterology & Hepatology Society, has created the largest awareness ribbon mosaic in honor of World Inflammatory Bowel Disease (IBD) Day Dubai, United Arab Emirates: In recognition of World Inflammatory Bowel Diseases (IBD) Day, Johnson & Johnson Innovative Medicine – Gulf, with the endorsement of Emirates Gastroenterology & Hepatology Society, has set a Guinness World Record for the largest awareness ribbon mosaic in support of Inflammatory Bowel Disease (IBD), highlighting the need for awareness and early diagnosis. The record-breaking installation spans 30 square meters and was assembled using over 20,000 purple IBD awareness ribbons. This powerful visual representation of solidarity aims to shed light on the challenges faced by IBD patients while symbolizing hope for improved care and increased awareness. Inflammatory Bowel Disease (IBD) is a group of chronic inflammatory conditions of the gastrointestinal tract and is divided into Crohn's disease and ulcerative colitis. The disease can significantly impact a patient's quality of life, often leading to persistent symptoms such as abdominal pain, fatigue, and unintended weight loss [2]. Recent study shows that IBD affects over 10 million people globally, reflecting its rising global burden and the growing need for timely diagnosis and long-term management [3]. Dr. Sameer Alawadhi, President of Emirates Gastroenterology & Hepatology Society said: 'Spreading awareness about Inflammatory Bowel Disease is an essential aspect of our mission, as timely diagnosis and intervention are crucial for effectively managing this chronic condition. This initiative not only offers hope to those living with IBD but also reflects the collective commitment of our healthcare community to improving patient care and outcomes.' Pedro Matos Rosa, Managing Director, Johnson & Johnson Innovative Medicine, Gulf, said: 'Inflammatory Bowel Disease is not only physically debilitating – it also carries a significant humanistic and economic burden. Addressing this multifaceted impact requires raising awareness, fostering innovation, and advancing solutions that ease these burdens and improve quality of life for all affected.' This initiative not only celebrates a creative and collective effort but also reinforces our ongoing commitment to supporting the IBD community and the healthcare professionals. With more than 30 years of leadership in IBD, Johnson & Johnson has contributed to advancing the understanding and management of the disease. Through continued investment and collaboration with healthcare professionals, the company remain committed to supporting improved outcomes for patients. By marking this Guinness World Record, the company reinforces its strategic goal to bring awareness, hope, and better outcomes to patients living with IBD across the region. About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more at For more information, please contact: Maroun Farah Email: MFarah@ [1] [2] [3]
Web Release
13-05-2025
- Web Release
Mayo Clinic researchers identify proteins linked to immunotherapy resistance in metastatic colorectal cancer
A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with metastatic colorectal cancer. In findings published in Clinical Cancer Research, the team identified specific proteins — fibronectin and smooth muscle actin — within colorectal cancer tissues that are associated with resistance to immunotherapy treatment. Immunotherapy is a major advance in treating cancer, but many patients, including those with metastatic colorectal cancer, do not respond to it. Until now, researchers have not known why. 'We need predictive biomarkers to guide the selection of immunotherapy for patients,' says medical oncologist and gastroenterologist Frank Sinicrope, M.D. , the senior author of the study. 'Identifying those who may have resistance to treatment can be useful because then we can spare them from receiving treatment that may not be beneficial and could produce significant toxicities.' The research team used digital spatial profiling, an advanced technology that simultaneously analyzes the expression of multiple proteins and where they are located within tissues. This approach allowed researchers to zoom in to get a bird's eye view of a tumor that includes proteins both within and surrounding the tumor cells and how they interact. Dr. Sinicrope compares the spatial tools to an aerial view of a neighborhood where one can see relationships between driveways, houses, yards and neighboring structures. Similarly, this detailed view provides physicians and researchers with critical information about the proteins in and around a patient's cancer, potentially informing the best treatment for the patient. 'We wanted to learn more about the patients who did not respond to immunotherapy. We investigated the leading edge of the tumor where cancer cells are invading and where the immune system is attempting to fight the cancer,' says Dr. Sinicrope. 'It's like a battle going on here and we're getting a snapshot into who is in attendance.' The researchers focused on 10 regions at the invasive margin of a tumor. They applied digital spatial profiling to investigate 71 distinct proteins in both the tumor's epithelial compartment and the surrounding stromal compartment. Fibronectin and smooth muscle actin are two extracellular matrix proteins that were found in the epithelial region of the tumor and were associated with resistance to immunotherapy and shorter time before disease progression. Upon further analysis, the researchers observed that cancer-associated fibroblasts were producing these proteins. The evidence, they say, suggests that these proteins can contribute to suppression of the anti-tumor immune response. The discovery offers a step toward more personalized and effective colorectal cancer treatments. Review the study for a complete list of authors, disclosures and funding.
Web Release
10-05-2025
- Web Release
Can diet help with inflammatory bowel disease?
Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative colitis and Crohn's disease. In this expert alert, Amanda Johnson, M.D. , a gastroenterologist at Mayo Clinic, helps explain IBD and whether diet can help. People with IBD may experience persistent symptoms like frequent diarrhea, weight loss, abdominal pain and fatigue. There is no cure and no exact cause, though researchers continue to look at how genes, the microbiome and environmental factors play a role in this chronic disease. 'Ulcerative colitis really tends to only involve the colon and be more of a superficial type inflammation; whereas Crohn's disease can impact anything in the intestine, essentially, from the mouth all the way down to the anus,' says Dr. Johnson. She says diet alone does not cause IBD. While some foods may reduce symptoms, there is no one proven diet to control inflammation. 'The right diet is probably different for each individual, based on the type of IBD that they have, the location of their disease, whether they've had surgeries or other complications,' says Dr. Johnson. Focus on fresh fruits and vegetables and whole grains. Avoid ultraprocessed foods, added sugars and animal fats. And drink plenty of water to stay hydrated. Diet does not replace medical treatment. Dr. Johnson says there are effective treatment options, so it is important to work with your healthcare team. 'The tenant of therapy we have are immune-suppressing-type therapies that try to target that inappropriate response to the intestines and then calm down that inflammation within the gut,' she says.
